Agilon Health (AGL) Common Equity (2020 - 2026)

Agilon Health (AGL) has 7 years of Common Equity data on file, last reported at $181.4 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 63.73% year-over-year to $181.4 million; the trailing twelve-month figure through Mar 2026 stood at $181.4 million (down 63.73% YoY), and the FY2025 full-year result was $126.7 million, down 73.09% from the prior year.
• Common Equity for Q1 2026 stood at $181.4 million, up from $126.7 million in the prior quarter.
• Across five years, Common Equity topped out at $1.1 billion in Q1 2022 and bottomed at $126.7 million in Q4 2025.
• The 5-year median for Common Equity is $675.9 million (2024), against an average of $692.3 million.
• The widest annual swing landed in 2022, when Common Equity jumped 472.67%; it then plunged 73.09% in 2025.
• A 5-year view of Common Equity shows it stood at $1.0 billion in 2022, then slumped by 36.48% to $661.0 million in 2023, then decreased by 28.75% to $471.0 million in 2024, then slumped by 73.09% to $126.7 million in 2025, then jumped by 43.16% to $181.4 million in 2026.
• The last three Common Equity figures came in at $181.4 million (Q1 2026), $126.7 million (Q4 2025), and $306.1 million (Q3 2025), per Business Quant data.

Peer Comparison